Breast Cancer

Breast Cancer

Next-Generation MRD Assay May Improve ctDNA Detection in Breast and Colorectal Cancers

November 19 4 min read
The next-generation Oncodetect assay combines tumor-informed whole-genome sequencing with MAESTRO (Minor Allele Enriched Sequencing Through Recognition Oligonucleotides), a technology originally developed by researchers at the Broad Institute of MIT and Harvard.

Latest in Breast Cancer